These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 3092653)
1. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia. Buchanan N; Laferla G; Hearns J; Buchanan KD; Crean GP; McColl KE Am J Med; 1986 Aug; 81(2A):40-3. PubMed ID: 3092653 [TBL] [Abstract][Full Text] [Related]
2. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. Thomas FJ; Koss MA; Hogan DL; Isenberg JI Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654 [TBL] [Abstract][Full Text] [Related]
3. Effect of enprostil on basal and meal-stimulated gastric acid and pepsin secretion, serum gastrin and gastric emptying in healthy persons. Berstad K; Massey H; Berstad A Aliment Pharmacol Ther; 1988 Feb; 2(1):65-72. PubMed ID: 2979235 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory action of enprostil (4,5-dehydro-16-phenoxy-17,18,19,20-tetranor-PGE2) on tetra-gastrin stimulated acid secretion in human subjects. Moriga M; Aono M; Narusawa H; Kohli Y; Kato T; Kajiyama G; Inoue M; Miyoshi A Gastroenterol Jpn; 1989 Apr; 24(2):115-9. PubMed ID: 2501133 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of the gastric acid and serum gastrin-lowering effects of the prostaglandin E2 analog enprostil. Baak LC; Jansen JB; Meijer JL; Lamers CB Clin Pharmacol Ther; 1993 Jun; 53(6):668-4. PubMed ID: 8513659 [TBL] [Abstract][Full Text] [Related]
6. Enprostil reduces the increase of gastric corpus mucosal mass induced by the hydrogen-potassium-stimulated adenosine triphosphatase inhibitor BY 831-78 in the rat. Inauen W; Rohner C; Koelz HR; Herdmann J; Schürer-Maly CC; Varga L; Halter F Gastroenterology; 1989 Oct; 97(4):846-52. PubMed ID: 2570729 [TBL] [Abstract][Full Text] [Related]
7. Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels. Florent C; Cogoni C; Joubert M; Desaint B Dig Dis Sci; 1990 Nov; 35(11):1352-7. PubMed ID: 2121423 [TBL] [Abstract][Full Text] [Related]
8. Central and peripheral effects of prostaglandin E2 and enprostil on gastric acid secretion in the rat. Sautereau D; Chicau-Chovet M; Tsocas A; Rozé C Eur J Pharmacol; 1991 Mar; 195(2):217-24. PubMed ID: 1678708 [TBL] [Abstract][Full Text] [Related]
9. Antisecretory effect of a PGE2 derivative, enprostil (TA/RS-84135): inhibitory action of amogastrin-stimulated secretion. Kohli Y; Katoh T; Suzuki K Drugs Exp Clin Res; 1988; 14(11):673-8. PubMed ID: 3149933 [TBL] [Abstract][Full Text] [Related]
10. Effect of enprostil, a synthetic prostaglandin E2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion. Deakin M; Ramage J; Paul A; Gray SP; Billings J; Williams JG Gut; 1986 Sep; 27(9):1054-7. PubMed ID: 3093317 [TBL] [Abstract][Full Text] [Related]
11. Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients. Bianchi Porro G; Lazzaroni M; Imbimbo BP; Sangaletti O; Ghirardosi C; Daniotti S Eur J Clin Pharmacol; 1987; 32(6):555-8. PubMed ID: 2888658 [TBL] [Abstract][Full Text] [Related]
12. The effect of H2-blockade on plasma gastrin concentration in patients with an achlorhydric stomach. Fullarton GM; Ardill JE; McColl KE Aliment Pharmacol Ther; 1992 Oct; 6(5):557-63. PubMed ID: 1358235 [TBL] [Abstract][Full Text] [Related]
13. Serum group I pepsinogens and gastrin in relation to gastric H+ and pepsin outputs before and after subcutaneous injection of pentagastrin. Waldum HL; Burhol PG; Straume BK Scand J Gastroenterol; 1978; 13(8):943-6. PubMed ID: 31675 [TBL] [Abstract][Full Text] [Related]
15. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease. Mahachai V; Walker K; Sevelius H; Thomson AB Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591 [TBL] [Abstract][Full Text] [Related]
16. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers. Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W Digestion; 1995; 56(2):137-44. PubMed ID: 7750667 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of hydrogen-potassium-stimulated adenosine triphosphatase: effects on acid secretion, plasma gastrin, and the gastric mucosa. McGuigan JE Gastroenterology; 1989 Oct; 97(4):1045-8. PubMed ID: 2550308 [No Abstract] [Full Text] [Related]
18. Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients. Tari A; Hamada M; Kamiyasu T; Sumii K; Haruma K; Inoue M; Kishimoto S; Kajiyama G; Walsh JH Dig Dis Sci; 1997 Aug; 42(8):1741-6. PubMed ID: 9286243 [TBL] [Abstract][Full Text] [Related]
19. Comparison of prostacyclin and prostaglandin E2 on gastric secretion, gastrin release, and mucosal blood flow in dogs. Konturek SJ; Robert A; Hanchar AJ; Nezamis JE Dig Dis Sci; 1980 Sep; 25(9):673-9. PubMed ID: 6998689 [TBL] [Abstract][Full Text] [Related]
20. The effect of a test meal on serum group I pepsinogens (PG I) and serum gastrin in persons with normal gastric H+ secretion and in persons with achlorhydria. Waldum HL; Jorde R; Burhol PG Scand J Gastroenterol; 1980; 15(3):267-71. PubMed ID: 7433884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]